Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

STRO Sutro Biopharma Inc

1,26

-0,08 (-5,97%)

Dernière mise à jour : 19:07:41

Retardé de 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sutro Biopharma (NASDAQ:STRO)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025

Plus de graphiques de la Bourse Sutro Biopharma

Sutro Biopharma (NASDAQ:STRO)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025

Plus de graphiques de la Bourse Sutro Biopharma

Actualités Sutro Biopharma Inc

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 6 Mars 2025 ( il y a 7 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 5 Mars 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 4 Mars 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 4 Mars 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
Lundi 3 Mars 2025 ( il y a 1 semaine) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Jeudi 27 Février 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mardi 7 Janvier 2025 ( il y a 2 mois) • GlobeNewswire Inc.

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale
Mardi 7 Janvier 2025 ( il y a 2 mois) • GlobeNewswire Inc.

Form 8-K - Current report
Mardi 10 Décembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer
Mardi 10 Décembre 2024 ( il y a 3 mois) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 3 Décembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Vendredi 15 Novembre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Plus d'articles sur Sutro Biopharma Inc

Cie de SaintGobain

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales